{"nctId":"NCT03170401","briefTitle":"Supplemental Enteral Protein in Critical Illness","startDateStruct":{"date":"2016-11","type":"ACTUAL"},"conditions":["Nutrition Disorder","Trauma","Critical Illness"],"count":500,"armGroups":[{"label":"no protein supplementation","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Standard enteral nutrition"]},{"label":"protein supplementation","type":"EXPERIMENTAL","interventionNames":["Dietary Supplement: Protein supplementation"]}],"interventions":[{"name":"Protein supplementation","otherNames":[]},{"name":"Standard enteral nutrition","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Critically ill adult trauma (blunt and penetrating) victims\n* Other critically ill surgical patients\n* enteral nutrition required during the first 96 hours after injury\n* expected to require nutritional support for at least 1 week\n\nExclusion Criteria:\n\n* Significant chronic organ failure,\n* severe malnutrition pre-existing prior to ICU admission\n* not expected to survive from their traumatic injuries.\n* intestinal discontinuity\n* short bowel syndrome\n* bowel obstruction\n* enterocutaneous fistula\n* intestinal ischemia\n* massive gastrointestinal hemorrhage\n* inability to obtain enteral access.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Serum Concentrations of Transthyretin at 3 Weeks After Injury.","description":"Transthyretin is a circulating biomarker of nutritional status and protein synthesis.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.1","spread":"8.0"},{"groupId":"OG001","value":"18.9","spread":"8.5"}]}]}]},{"type":"SECONDARY","title":"Ventilator-free Days.","description":"Ventilator-free days will measured in the standard way and indicate the number of days a subject was alive and not receiving mechanical ventilation during the first 28 days.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.0","spread":"9.7"},{"groupId":"OG001","value":"13.9","spread":"9.8"}]}]}]},{"type":"SECONDARY","title":"Ventilator Associated Pneumonia.","description":"Pneumonia diagnosed while the patient is receiving mechanical ventilation as recorded in the institutional administrative trauma registry and ICU quality assurance database.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":31,"n":256},"commonTop":["Diarrhea","Abdominal distention","Emesis"]}}}